(Q28361771)

4 July 2017

title

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin) (English)

1 reference

4 July 2017

main subject

arterial hypertension

1 reference

primary pulmonary hypertension

inferred from title

1 reference

Jones DK

1

1 reference

4 July 2017

Higenbottam TW

series ordinal

2

1 reference

4 July 2017

Wallwork J

series ordinal

3

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

4 July 2017

published in

British Heart Journal

1 reference

4 July 2017

volume

57

1 reference

4 July 2017

issue

3

1 reference

4 July 2017

page(s)

270-278

1 reference

Hazards of diazoxide in pulmonary hypertension

4 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Management of primary pulmonary hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Oral hydralazine therapy for primary pulmonary hypertension.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Noninvasive assessment of hemodynamic improvement during chronic vasodilator therapy in obliterative pulmonary hypertension.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

The measurement of metabolic gas exchange and minute volume by mass spectrometry alone

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Right-sided infective endocarditis as a consequence of flow-directed pulmonary-artery catheterization. A clinicopathological study of 55 autopsied patients

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

Intrapulmonary veno-occlusive disease

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1216424

LOSS OF REACTIVITY OF THE PULMONARY VASCULAR BED IN PRIMARY PULMONARY HYPERTENSION

27 November 2018

1 reference

12 December 2020

Diazoxide in primary pulmonary hypertension

1 reference

12 December 2020

Vasodilator therapy for pulmonary hypertension

1 reference

12 December 2020

Unexplained pulmonary hypertension

1 reference

12 December 2020

Deleterious effects of hydralazine in patients with pulmonary hypertension

1 reference

12 December 2020

Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure

1 reference

12 December 2020

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

1 reference

12 December 2020

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

12 December 2020

Rebound platelet activation during continuous epoprostenol infusion

1 reference

12 December 2020

Clinical primary pulmonary hypertension: three pathologic types

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.57.3.270

1 reference

4 July 2017

1 reference

4 July 2017

1 reference